RELX · RELX PLC PLC
$32.86
+0.37% last session
End-of-day data · updated 2026-07-25
Market cap
$60B
Enterprise value
$250B
Trailing P/E
—
Forward P/E
16.2
Dividend yield
3.0%
Beta
0.26
Avg volume
3M
Employees
37K
2D change
4.72%
5D change
0.91%
10D change
2.69%
30D change
11.29%
60D change
4.59%
MTD change
9.66%
YTD change
-13.20%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RELX
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-04-08
Latest call per bank · past 12 months
Citigroup
Buy$0.00
-100.0% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-04-08 | Citigroup | Upgrade | Neutral → Buy | $0.00 |
| 2026-01-12 | Citigroup | Initiates | Neutral | $0.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 50 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 0.2% above the 50-day MA ($32.80).
- Price vs 200-day MA: Trading 9.4% below the 200-day MA ($36.27).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+0.09) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($27.20) and high ($52.40).
RELX Price Chart
Loading chart for RELX…
Fundamentals
About RELX PLC PLC
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
More in Specialty Business Services
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.